Concepedia

Eytan M. Stein

EM

128

Publications

13.8K

Citations

43

H-Index

1986

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Massachusetts General Hospital

Institut Gustave Roussy

Eytan M. Stein is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

1986–2025

128

Publications

128

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Hartmut Döhner, Andrew H. Wei, Frederick R. Appelbaum et al. · Blood · 2022 · 2.7K citations · Full text

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea et al. · Blood · 2017 · 1.4K citations · Full text

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

Eytan M. Stein, Guillermo Garcia‐Manero, David A. Rizzieri et al. · Blood · 2018 · 442 citations · Full text

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio et al. · Nature · 2023 · 420 citations · Full text

Rows per page

1–5 of 128